Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Novo Nordisk A/S ADR buy Quitte

Start price
€42.14
15.08.16 / 50%
Target price
€44.65
15.02.17
Performance (%)
-26.05%
End price
€31.16
15.02.17
Summary
This prediction ended on 15.02.17 with a price of €31.16. The prediction for Novo Nordisk A/S ADR disappointed with a performance of -26.05%. Quitte has 50% into this prediction
Performance without dividends (%)
Name 1w 1m 1y 3y
Novo Nordisk A/S ADR 2.510% 2.510% -20.712% 87.883%
iShares Core DAX® -0.051% 4.829% 17.062% 18.811%
iShares Nasdaq 100 1.659% 2.417% 38.705% 56.555%
iShares Nikkei 225® 0.658% -2.173% 13.159% 7.768%
iShares S&P 500 0.964% 2.547% 30.492% 47.355%

Comments by Quitte for this prediction

In the thread Novo Nordisk A/S ADR diskutieren
Prediction Buy
Perf. (%) -26.05%
Target price 44.649
Change
Ends at 15.02.17

übertrieben

sooo schrecklich waren die Zahlen nicht

Analysten bleiben positiv

Prediction Buy
Perf. (%) -26.05%
Target price 44.649
Change
Ends at 15.02.17

(Laufzeit überschritten)